Ricardo Marcos‐Pinto
0000-0001-9695-8261
Publication & Citation Trends
Publications
109 total
Long‐Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp‐EuReg)
Cited by 0
Semantic Scholar
Lack of follow-up in Helicobacter pylori eradication treatment: Results from the European registry on Helicobacter pylori management
Cited by 0
Semantic Scholar
Real‐World Effectiveness and Safety of Saccharomyces boulardii CNCM I‐745 as Adjunct Therapy for Helicobacter pylori Eradication: Data From the European Registry on H. pylori Management (Hp‐EuReg)
Cited by 0
Semantic Scholar
Malignant Small Bowel Neoplasms: A 20-Year Retrospective Analysis in a Tertiary Center
Cited by 0
Semantic Scholar
Alterations in mucosa branched N-glycans lead to dysbiosis and downregulation of ILC3: a key driver of intestinal inflammation OA
Cited by 5
Semantic Scholar
External Multicentre Validation of the FAMISH Score for Predicting Metachronous Gastric Lesions After Endoscopic Submucosal Dissection
Cited by 0
Semantic Scholar
External multicenter validation of the FAMISH score for predicting metachronous gastric lesions after endoscopic submucosal dissection
Cited by 0
Semantic Scholar
Reprogramming CD8+ T-cell branched N-glycosylation limits exhaustion, enhancing cytotoxicity and tumor killing.
Cited by 3
Semantic Scholar
PROBIOTICS PRESCRIBED WITH HELICOBACTER PYLORI ERADICATION THERAPY IN EUROPE: USAGE PATTERN, EFFECTIVENESS, AND SAFETY: Results from the European Registry on Helicobacter pylori Management (Hp-EuReg).
Cited by 9
Semantic Scholar
Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019 PDF
Cited by 943
OpenAlex
Research Topics
Helicobacter pylori-related gastroenterology studies
(44)
Gastric Cancer Management and Outcomes
(34)
Glycosylation and Glycoproteins Research
(16)
Immunotherapy and Immune Responses
(14)
Gastrointestinal disorders and treatments
(13)
Affiliations
Universidade do Porto
Technologies pour la Santé
Instituto Português de Oncologia Francisco Gentil
Administração Regional de Saúde de Lisboa e Vale do Tejo
IPO Porto